Claudia Lin PhD

Dr. Claudia Lin is a China 1000 Innovation Talent Award recipient, and an Innovation and Entrepreneur Leadership Award recipient at SIP. She was born and raised in Shanghai and went to Fudan University. She then went to the US and obtained her Ph.D degree in Cell and Molecular Biology from University of California at Berkeley. During and after her post-doctoral training, she conducted basic and translational research in cancer and other diseases areas. For the past 15 years, her career has been focused on CMC, manufacturing and Quality. Dr. Lin held various Quality leadership positions in Genentech/ROCHE including QA and QC functions for clinical development, as well as technology transfer and Annual Product Quality Review for ROCHE global commercial biologics portfolio.

she was head of Quality Assurance for Bayer Healthcare Biotech division in California, responsible for all products in clinical development. She was also involved in the work of global leading monoclonal antibody products listing. Dr. Lin is a reputable biotech Quality professional in the US and in Asia and is a regular speaker in international conferences. When Dr. Lin first came back to China in early 2015, she worked as Vice President at a leading biopharma in China, responsible for GMP compliance and Quality management. Later, GM position for another leading Chinese biopharma. Dr. Lin founded Suzhou Jade Biomedical Co., Ltd. in May 2017, dedicated to providing world-class quality management services to the China Biopharm industry.